Spots Global Cancer Trial Database for urothelial
Every month we try and update this database with for urothelial cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder | NCT02202772 | Urothelial Carc... | Cabazitaxel Gemcitabine Cisplatin | 18 Years - | Columbia University | |
| ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) | NCT04044859 | Endometrial Can... Esophageal Canc... Esophagogastric... Gastric (Stomac... Head and Neck C... Melanoma Ovarian Cancer Non-small Cell ... Urothelial Canc... | Autologous gene... | 18 Years - 75 Years | Adaptimmune | |
| Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer | NCT01700010 | Urothelial Canc... Bladder Cancer | Lapatinib and P... | 18 Years - | University of Michigan Rogel Cancer Center | |
| Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer | NCT03150836 | Bladder Cancer | Durvalumab Tremelimumab Radiation Thera... | 18 Years - | University of California, San Francisco | |
| Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer | NCT00237575 | Bladder Cancer | gemcitabine cisplatin sargramostim filgrastim | 18 Years - | University of Kentucky | |
| Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer | NCT00350025 | Urologic Neopla... | Cetuximab Paclitaxel | 18 Years - | Fox Chase Cancer Center | |
| Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer | NCT00237575 | Bladder Cancer | gemcitabine cisplatin sargramostim filgrastim | 18 Years - | University of Kentucky | |
| Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC) | NCT01663285 | Urothelial Canc... Bladder Cancer | Neoadjuvant Cis... | 18 Years - | University of Michigan Rogel Cancer Center | |
| Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer | NCT00350025 | Urologic Neopla... | Cetuximab Paclitaxel | 18 Years - | Fox Chase Cancer Center | |
| Durvalumab Plus Olaparib Administered Prior to Surgery of Resectable Urothelial Bladder Cancer (NEODURVARIB) | NCT03534492 | Bladder Cancer | Durvalumab Olaparib | 18 Years - | Spanish Oncology Genito-Urinary Group | |
| Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) | NCT02710734 | Urothelial Carc... | Methotrexate Vinblastine Doxorubicin Cisplatin Intensity modul... Transurethral R... 5-FU Mitomycin C | 18 Years - | Fox Chase Cancer Center | |
| Durvalumab Plus Olaparib Administered Prior to Surgery of Resectable Urothelial Bladder Cancer (NEODURVARIB) | NCT03534492 | Bladder Cancer | Durvalumab Olaparib | 18 Years - | Spanish Oncology Genito-Urinary Group | |
| Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer | NCT03150836 | Bladder Cancer | Durvalumab Tremelimumab Radiation Thera... | 18 Years - | University of California, San Francisco | |
| A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer | NCT03785925 | Urinary Bladder... Neoplasm Metast... | Bempegaldesleuk... Nivolumab | 18 Years - | Nektar Therapeutics |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
